Subnormal alanine aminotransferase values in blood of patients with Crohn disease

Scandinavian Journal of Gastroenterology

Volumn 39, Issue 6, 2004, Pages 554-556

  Vadstrup, S ^a  

^a HOLBÆK HOSPITAL   (Denmark)

Author keywords

Alanine aminotransferase; ALAT; ALT; Crohn disease; Inflammatory bowel disease; Microscopic colitis; Oxalate; PLP; Pyridoxal 5 phosphate; Ulcerative colitis

Indexed keywords

ALANINE AMINOTRANSFERASE; AZATHIOPRINE; BUDESONIDE; PREDNISOLONE;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; CONTROLLED STUDY; CROHN DISEASE; FEMALE; HUMAN; ILEOSTOMY; LIVER DISEASE; LIVER FUNCTION; MAJOR CLINICAL STUDY; MALE; OUTPATIENT; PATIENT SELECTION; PRIORITY JOURNAL; ULCERATIVE COLITIS;

ADULT; ALANINE TRANSAMINASE; BIOLOGICAL MARKERS; COLITIS, ULCERATIVE; CROHN DISEASE; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 3142693543     PISSN: 00365521     EISSN: None     Source Type: Journal    
DOI: 10.1080/00365520410005162     Document Type: Article

References (15)

1. Prati D, Taioli E, Zanella A, Della Torre E, Butelli S, Del Vecchio E, et al. Updated definitions of healthy range for serum alanine aminotransferase levels. Ann Intern Med 2002;137:1-9.
2. Kaplan MM. Alanine aminotransferase levels: what's normal. [Editorial]. Ann Intern Med 2002;137:49-51.
3. Cohen GA, Goffinet JA, Donabedian RK, Conn HO. Observations on decreased serum glutamic oxalacetic transaminase (SGOT) activity in azotemic patients. Ann Intern Med 1976;84: 275-80.
4. Ono K, Ono T, Matsumata T. The pathogenesis of decreased aspartate aminotransferase and alanine aminotransferase activity in the plasma of hemodialysis patients: the role of vitamin B6 deficiency. Clin Nephol 1995;43:405-8.
5. Yasada K, Okuda K, Endo N, Ishiwatari Y, Ikeda R, Hayashi H, et al. Hypo-aminotransferasemia in patients undergoing long-term hemodialysis: clinical and biochemical appraisal. Gastroenterology 1995;109:1295-300.
6. Tietz NW, Wekstein DR, Shuey DF, Brauer GA. A two-year longitudinal reference range study for selected serum enzymes in a population more than 60 years of age. J Am Geriatr Soc 1984; 32:563-70.
7. Klauke R, Schmidt E, Lorentz K. Recommendations for carrying out standard ECCLS procedures (1988) for the catalytic concentrations of creatinine kinase, aspartate aminotransferase, alanine amino transferase and gamma- glutamyltransferase at 37 degrees C. Eur J Clin Chem Clin Biochem 1993;31:901-9.
8. Leino A, Impivaara O, Irjala K, Maki J, Peltols O, Jarvisalo J. Health-based reference intervals for ALAT, ASAT and GT in serum, measured according to the recommendations of the European Committee for Clinical Laboratory Standards (ECCLS). Scand J Clin Lab Invest 1995;55:243-50.
9. Vanderlinde RE. Review of pyridoxal phosphate and the transaminases in liver disease. Ann Clin Lab Sci 1986;16:79-93.
10. Diehl AM, Potter J, Boitnott J, Van Duyn MA, Herlong HF, Mezey E. Relationship between pyridoxal 5′-phosphate deficiency and aminotransferase levels in alcoholic hepatitis. Gastroenterology 1984;86:632-6.
11. Balcke P, Schmidt P, Zazgornik J, Kopsa H, Deutsch E. Secondary oxalosis in chronic renal insufficiency. Z Urol Nephrol 1982;75:409-14.
12. Balcke P. Oxalic acid metabolism in chronic renal failure. Wien Klin Wochenschr 1985;Suppl 160:1-15.
13. Edwards P, Rose GA. Metabolism of pyridoxine in mild metabolic hyperoxaluria and primary hyperoxaluria (type 1). Urol Int 1991;47:113-7.
14. Sangaletti O, Petrillo M, Porro GB. Urinary oxalate recovery after oral oxalic load: an alternative method to the quantitative determination of stool-fat for the diagnosis of lipid malabsorption. Int Med Res 1989;17:526-31.
15. McConnell N, Campbell S, Gillanders I, Rolton H, Danesk B. Risk factors for developing renal stones in inflammatory bowel disease. Br J Urol Int 2002;89:835-41.